The Hanover Insurance Group (THG) – Research Analysts’ Weekly Ratings Updates

The Hanover Insurance Group (NYSE: THG) recently received a number of ratings updates from brokerages and research firms:

• 5/19/2026 – The Hanover Insurance Group was downgraded by BMO Capital Markets from “outperform” to “market perform”. They now have a $203.00 price target on the stock, up from $194.00.
• 5/8/2026 – The Hanover Insurance Group was upgraded by Weiss Ratings from “buy (b)” to “buy (b+)”.
• 5/7/2026 – The Hanover Insurance Group had its price target raised by Keefe, Bruyette & Woods from $208.00 to $211.00. They now have an “outperform” rating on the stock.
• 5/4/2026 – The Hanover Insurance Group was upgraded by Zacks Research from “hold” to “strong-buy”.
• 5/1/2026 – The Hanover Insurance Group was given a new $195.00 price target by Morgan Stanley.
• 5/1/2026 – The Hanover Insurance Group had its price target raised by Piper Sandler from $204.00 to $212.00. They now have an “overweight” rating on the stock.
• 5/1/2026 – The Hanover Insurance Group had its price target raised by Royal Bank Of Canada from $190.00 to $195.00. They now have a “sector perform” rating on the stock.
• 4/30/2026 – The Hanover Insurance Group had its “outperform” rating reaffirmed by Citigroup Inc..
• 4/30/2026 – The Hanover Insurance Group had its price target raised by Citizens Jmp from $200.00 to $205.00. They now have a “market outperform” rating on the stock.
• 4/20/2026 – The Hanover Insurance Group had its “buy (b)” rating reaffirmed by Weiss Ratings.
• 4/7/2026 – The Hanover Insurance Group had its price target lowered by Royal Bank Of Canada from $200.00 to $190.00. They now have a “sector perform” rating on the stock.
• 4/6/2026 – The Hanover Insurance Group had its price target lowered by Morgan Stanley from $194.00 to $190.00. They now have an “equal weight” rating on the stock.

The Hanover Insurance Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 27th. Investors of record on Friday, March 13th were issued a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date was Friday, March 13th. The Hanover Insurance Group’s dividend payout ratio (DPR) is 19.12%.

Insiders Place Their Bets

In other The Hanover Insurance Group news, Director Cynthia Egan sold 3,400 shares of the business’s stock in a transaction on Friday, May 1st. The stock was sold at an average price of $188.50, for a total value of $640,900.00. Following the transaction, the director owned 9,359 shares of the company’s stock, valued at approximately $1,764,171.50. The trade was a 26.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO John C. Roche sold 5,251 shares of the firm’s stock in a transaction on Monday, May 18th. The shares were sold at an average price of $198.06, for a total value of $1,040,013.06. Following the sale, the chief executive officer directly owned 141,011 shares of the company’s stock, valued at approximately $27,928,638.66. This represents a 3.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 15,088 shares of company stock valued at $2,898,590. 2.80% of the stock is owned by insiders.

The Hanover Insurance Group, Inc (NYSE: THG) is a property and casualty insurance company that provides a range of commercial and personal insurance products. Through its subsidiary companies, Hanover offers coverage for businesses of all sizes, including workers’ compensation, general liability, commercial auto, and professional liability. On the personal lines side, the company underwrites homeowners, personal auto, flood, and umbrella policies designed to meet the needs of individuals and families.

In addition to its core commercial and personal insurance offerings, Hanover maintains a specialty arm that focuses on niche markets through tailored product solutions.